Javascript must be enabled to continue!
Treatment of Aggressive Pituitary Adenomas and CarcinomasAn Overview
View through CrossRef
Most pituitary tumors are non-invasive, benign adenomas that remain confined to the sella turcica. Some of them recur, have a rapid growth rate, and invade surrounding tissues. These adenomas, considered aggressive pituitary tumors, are difficult to manage and present problems due to incomplete resection. A pituitary carcinoma is diagnosed when craniospinal and/or systemic metastases are documented. Treatment options for pituitary adenomas are surgery, radiation, and drugs. Recent publications report the efficacy of temozolomide in the treatment of aggressive pituitary adenomas and carcinomas. Indications for, results with, and side effects of temozolomide therapy in aggressive pituitary tumors and pituitary carcinomas are reviewed here. Alternative treatment options for resistant or recurrent pituitary tumors are also discussed.
Touch Medical Media, Ltd.
Title: Treatment of Aggressive Pituitary Adenomas and CarcinomasAn Overview
Description:
Most pituitary tumors are non-invasive, benign adenomas that remain confined to the sella turcica.
Some of them recur, have a rapid growth rate, and invade surrounding tissues.
These adenomas, considered aggressive pituitary tumors, are difficult to manage and present problems due to incomplete resection.
A pituitary carcinoma is diagnosed when craniospinal and/or systemic metastases are documented.
Treatment options for pituitary adenomas are surgery, radiation, and drugs.
Recent publications report the efficacy of temozolomide in the treatment of aggressive pituitary adenomas and carcinomas.
Indications for, results with, and side effects of temozolomide therapy in aggressive pituitary tumors and pituitary carcinomas are reviewed here.
Alternative treatment options for resistant or recurrent pituitary tumors are also discussed.
Related Results
Neuroimaging Assessment of Aggressive Pituitary Adenomas
Neuroimaging Assessment of Aggressive Pituitary Adenomas
Aggressive pituitary adenomas (APA) are adenomas that show rapid growth, invasiveness, frequent or multiple relapses, or are resistant to conventional therapies. Clinical-imaging a...
Treatment of Aggressive Pituitary Adenomas and Carcinomas – An Overview
Treatment of Aggressive Pituitary Adenomas and Carcinomas – An Overview
Most pituitary tumours are non-invasive, benign adenomas that remain confined to the sella turcica. Some of them recur, have a rapid growth rate, and invade surrounding tissues. Th...
Plurihormonal pituitary macroadenoma: a case report
Plurihormonal pituitary macroadenoma: a case report
Abstract
Background
Plurihormonal pituitary adenomas are a unique type of pituitary adenomas that secrete two or more pituitary hormones normally as...
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract
Introduction: Current study found that about one-third of the incidence of colorectal cancer have genetic related. Hereditary nonpolyposis colorectal cancer...
Growth Hormone (GH) Deficiency (GHD) of Childhood Onset: Reassessment of GH Status and Evaluation of the Predictive Criteria for Permanent GHD in Young Adults
Growth Hormone (GH) Deficiency (GHD) of Childhood Onset: Reassessment of GH Status and Evaluation of the Predictive Criteria for Permanent GHD in Young Adults
GH secretion was reevaluated after completion of GH treatment at a mean age of 19.2 ± 3.2 yr in 35 young adults with childhood-onset GH deficiency (GHD). The patients were subdivid...
COVID-19 induced hypercoagulability and its impact leading to pituitary apoplexy
COVID-19 induced hypercoagulability and its impact leading to pituitary apoplexy
I am writing this letter to address an increasingly high-risk but under-explored complication of pituitary apoplexy in patients who have contracted COVID-19. In light of recent res...
Abstract 739: Increased mortality in patients with pituitary adenomas
Abstract 739: Increased mortality in patients with pituitary adenomas
Abstract
Purpose: To evaluate mortality rate and causes of death in patients with pituitary adenomas. Material & Methods: Five hundred seventy-two patients with ...
Molecular pathogenesis of pituitary tumours
Molecular pathogenesis of pituitary tumours
Abstract
Pituitary adenomas are discovered in up to 25% of unselected autopsies, however, clinically apparent tumours are considerably less common. The pituitary gla...

